CMMB

Chemomab Therapeutics Ltd.

Healthcare · Biotechnology

$159.82 sample

-0.61 (-0.38%) 1D

Market cap

$253.1B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-28

Alerts

8

Price$159.82 +15.74% 3M daily closessample

163.19134.52

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: General Counsel
Oct 07INSInsider sell: General Counsel
Oct 02INSInsider sell: 10% owner
Sep 28SECDEF 14A filed
Sep 23SECForm 144 filed
Sep 18SEC10-Q filed
Sep 14INSInsider sell: EVP, Operations
Sep 07INSInsider buy: General Counsel

Sign up to see the real CMMB record →

Company facts

SEC EDGAR registration

Name: Chemomab Therapeutics Ltd.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -12sample, -100 to +100
Reporting currency: USD

Who is positioning in CMMB

sample

Insiders: 27 insider transactions over 90 days, net selling, $206.7M
Congress: No member trades over 90 days
Institutions · 13F: 28 funds hold $5.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$15.9B +14.4% y/y

Q4 2024Q3 2026

Inventory$9.6B +16.3% y/y

Q4 2024Q3 2026

Accounts receivable$6.8B +8.5% y/y

Q4 2024Q3 2026

Total debt$19.3B +14.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $32.0B +8.3% 3M
Sample peer B: $41.5B -9.1% 3M
Sample peer C: $223.2B -7.1% 3M
Sample peer D: $109.8B +10.7% 3M
Sample peer E: $134.3B +8.6% 3M